Skip to main content
Log in

What is migraine? Controversy and stalemate in migraine pathophysiology

  • Review Of Migraine And Its Therapy
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Summary

Theories of migraine pathophysiology have evolved from the realms of the supernatural into the scientific arena but their further evolution seems delayed by unproductive controversy about whether or not migraine is primarily a vascular or a neurological dysfunction. This conceptual deadlock needs to be transcended by thinking beyond the neural and vascular systems, and by identifying mechanisms that could affect both to produce the characteristic clinical phenomena of migraine. One theoretical model envisages 5-hydroxytryptamine (serotonin; 5-HT) as a link between the neural and vascular systems, with global alteration of serotonergic neurotransmission affecting not only these systems, but the gastrointestinal tract as well, with incidental reverberations on platelet function. Such altered serotonergic transmission might originate from altered 5-HT receptor dynamics, a molecular change in turn produced by genetic mechanisms. Recognition of the importance of 5-HT receptor function in migraine, most notably that agonists of 5-HT1 receptors abort acute migraine and that antagonists of 5-HT2 receptors prevent migraine, may lead to significant therapeutic advances. The possibility that the “trigeminovascular system” might be the end-stage mechanism that these serotonergic changes detonate to produce the painful reverberations of migraine headache is also important. Seeking ways to muffle these reverberations, or to insulate the system itself from the action of external influences (likely through further study of peptidergic transmission and receptors) might result in more drugs that will abort or prevent migraine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Anthony M, Hinterberger H, Lance JW (1969) The possible relationship of serotonin to the migraine syndrome. In: Friedman AP (ed) Research and clinical studies in headache, vol 2. Karger, New York, pp 29–59

    Google Scholar 

  2. Curzon G, Barie M, Wilkinson MIP (1969) Relationship between headache and amine changes after administration of reserpine to migrainous patients. J Neurol Neurosurg Psychiatry 32:555–561

    Google Scholar 

  3. D'Andrea G, Toldo M, Cortelazzo S, Milone FF (1982) Platelet activity in migraine. Headache 22:207–212

    Google Scholar 

  4. Davies PTG, Steiner TJ (1990) Serotonin S2 receptors and migraine: a study with the selective antagonist ICI 169,369. Headache 30:340–343

    Google Scholar 

  5. Gawel M, Burkitt M, Clifford Rose F (1979) The platelet release reaction during migraine attacks. Headache 19:323–327

    Google Scholar 

  6. Graham JR, Wolff HG (1938) Mechanism of migraine headache and action of ergotamine tartrate. Arch Neurol Psychiatry 39:737–763

    Google Scholar 

  7. Hanington E, Jones RJ, Amess JAL, Wachowicz B (1981) Migraine — a platelet disorder. Lancet II:720–723

    Google Scholar 

  8. Hilton BP, Cumings JN (1972) 5-Hydroxytryptamine levels and platelet aggregation responses in subjects with acute migraine headache. J Neurol Neurosurg Psychiatry 35:505–509

    Google Scholar 

  9. Humphrey PPA, Feniuk W, Perren MJ (1990) Anti-migraine drugs in development: advances in serotonin receptor pharmacology. Headache 30:12–16

    Google Scholar 

  10. Kimball RW, Friedman AP, Vallejo E (1960) Effect of serotonin in migraine patients. Neurology 10:107–111

    Google Scholar 

  11. Lance JW, Lambert GA, Goadsby PJ, Duckworth JW (1983) Brainstem influences on the cephalic circulation: experimental data from cat and monkey of relevance to the mechanism of migraine. Headache 23:258–265

    Google Scholar 

  12. Lashley KS (1941) Patterns of cerebral integration indicated by the scotomas of migraine. Arch Neurol Psychiatry 46:259–264

    Google Scholar 

  13. Leao AAP (1944) Spreading depression of activity in cerebral cortex. J Neurophysiol 7:359–390

    Google Scholar 

  14. Moskowitz MA (1984) The neurobiology of vascular head pain. Ann Neurol 16:157–168

    Google Scholar 

  15. Moynihan B (1920) On advances in science. Surg Gynecol Obstet 31:549–552

    Google Scholar 

  16. Olesen J, Larsen B, Lauritzen M (1981) Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol 9:344–352

    Google Scholar 

  17. Peroutka SJ (1990) The pharmacology of current anti-migraine drugs. Headache 30:5–11

    Google Scholar 

  18. Schiller F (1975) The migraine tradition. Bull Hist Med 49:1–19

    Google Scholar 

  19. Schumacher JA, Wolff HG (1941) Experimental studies on headache. Arch Neurol Psychiatry 45:199–214

    Google Scholar 

  20. Skyhøj Olsen T (1990) Migraine with and without aura: the same disease due to cerebral vasospasm of different intensity. A hypothesis based on CBF studies during migraine. Headache 30:269–272

    Google Scholar 

  21. Steiner TJ, Joseph R, Clifford Rose F (1985) Migraine is not a platelet disorder. Headache 25:434–440

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Edmeads, J. What is migraine? Controversy and stalemate in migraine pathophysiology. J Neurol 238 (Suppl 1), S2–S5 (1991). https://doi.org/10.1007/BF01642898

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01642898

Key words

Navigation